Dr. Reddy’s, Hospira Asks Appeals Court to Re-Hear Alimta Patent Case

Drug Industry Daily
A A
Dr. Reddy’s and Hospira have asked a federal appeals court to reconsider a patent infringement ruling regarding Eli Lilly’s cancer drug Alimta (permetrexed).

To View This Article:

Login

Subscribe To Drug Industry Daily